Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

714 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.
Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ; Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. Van Gelder IC, et al. Among authors: tijssen jg. N Engl J Med. 2002 Dec 5;347(23):1834-40. doi: 10.1056/NEJMoa021375. N Engl J Med. 2002. PMID: 12466507 Free article. Clinical Trial.
In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes.
Vis MM, Sjauw KD, van der Schaaf RJ, Baan J Jr, Koch KT, DeVries JH, Tijssen JG, de Winter RJ, Piek JJ, Henriques JP. Vis MM, et al. Among authors: tijssen jg. Am Heart J. 2007 Dec;154(6):1184-90. doi: 10.1016/j.ahj.2007.07.028. Epub 2007 Sep 12. Am Heart J. 2007. PMID: 18035093
Presence of older thrombus is an independent predictor of long-term mortality in patients with ST-elevation myocardial infarction treated with thrombus aspiration during primary percutaneous coronary intervention.
Kramer MC, van der Wal AC, Koch KT, Ploegmakers JP, van der Schaaf RJ, Henriques JP, Baan J Jr, Rittersma SZ, Vis MM, Piek JJ, Tijssen JG, de Winter RJ. Kramer MC, et al. Among authors: tijssen jg. Circulation. 2008 Oct 28;118(18):1810-6. doi: 10.1161/CIRCULATIONAHA.108.780734. Epub 2008 Oct 13. Circulation. 2008. PMID: 18852369
Impact of pretreatment with clopidogrel on initial patency and outcome in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review.
Vlaar PJ, Svilaas T, Damman K, de Smet BJ, Tijssen JG, Hillege HL, Zijlstra F. Vlaar PJ, et al. Among authors: tijssen jg. Circulation. 2008 Oct 28;118(18):1828-36. doi: 10.1161/CIRCULATIONAHA.107.749531. Epub 2008 Oct 13. Circulation. 2008. PMID: 18852370 Review.
Two year follow-up after primary PCI with a paclitaxel-eluting stent versus a bare-metal stent for acute ST-elevation myocardial infarction (the PASSION trial): a follow-up study.
Dirksen MT, Vink MA, Suttorp MJ, Tijssen JG, Patterson MS, Slagboom T, Kiemeneij F, Laarman GJ; Paclitaxel-Eluting Stent versus Conventional Stent; in Myocardial Infarction with ST-Segment Elevation (PASSION) investigators. Dirksen MT, et al. Among authors: tijssen jg. EuroIntervention. 2008 May;4(1):64-70. doi: 10.4244/eijv4i1a12. EuroIntervention. 2008. PMID: 19112781 Clinical Trial.
714 results